Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

医学 癌症 重症监护医学 化疗 抗癌药物 药品 肿瘤科 内科学 药理学
作者
Uttpal Anand,Abhijit Dey,Arvind K. Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh J. L. Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José Manuel Pérez de la Lastra
出处
期刊:Genes and Diseases [Elsevier BV]
卷期号:10 (4): 1367-1401 被引量:2011
标识
DOI:10.1016/j.gendis.2022.02.007
摘要

Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and produce aggressive malignancies that causes millions of deaths every year. With the new understanding of the molecular mechanism(s) of disease progression, our knowledge about the disease is snowballing, leading to the evolution of many new therapeutic regimes and their successive trials. In the past few decades, various combinations of therapies have been proposed and are presently employed in the treatment of diverse cancers. Targeted drug therapy, immunotherapy, and personalized medicines are now largely being employed, which were not common a few years back. The field of cancer discoveries and therapeutics are evolving fast as cancer type-specific biomarkers are progressively being identified and several types of cancers are nowadays undergoing systematic therapies, extending patients' disease-free survival thereafter. Although growing evidence shows that a systematic and targeted approach could be the future of cancer medicine, chemotherapy remains a largely opted therapeutic option despite its known side effects on the patient's physical and psychological health. Chemotherapeutic agents/pharmaceuticals served a great purpose over the past few decades and have remained the frontline choice for advanced-stage malignancies where surgery and/or radiation therapy cannot be prescribed due to specific reasons. The present report succinctly reviews the existing and contemporary advancements in chemotherapy and assesses the status of the enrolled drugs/pharmaceuticals; it also comprehensively discusses the emerging role of specific/targeted therapeutic strategies that are presently being employed to achieve better clinical success/survival rate in cancer patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
KuoHu完成签到 ,获得积分20
刚刚
刚刚
菜菜关注了科研通微信公众号
1秒前
外向书萱关注了科研通微信公众号
1秒前
慕青的应助被佛光辉采纳,获得10
1秒前
受伤的尔冬完成签到,获得积分10
1秒前
汉堡包的应助被WT采纳,获得10
2秒前
2秒前
2秒前
飞跃极限完成签到 ,获得积分10
3秒前
3秒前
深情安青的应助被LiuShenglan采纳,获得10
3秒前
3秒前
3秒前
4秒前
ccc发布了新的文献求助10
4秒前
范志鹏完成签到,获得积分20
5秒前
KuoHu关注了科研通微信公众号
5秒前
波风水门完成签到,获得积分10
5秒前
6秒前
万能图书馆的应助被tayyy采纳,获得10
6秒前
范志鹏发布了新的文献求助10
7秒前
7秒前
苒苒发布了新的文献求助10
7秒前
面包恐龙发布了新的文献求助10
7秒前
molihuakai的应助被7Wen采纳,获得10
8秒前
ldz完成签到 ,获得积分20
8秒前
wobisheng完成签到,获得积分10
8秒前
9秒前
晚风与海盐完成签到 ,获得积分10
9秒前
波风水门发布了新的文献求助10
9秒前
Jason完成签到 ,获得积分10
9秒前
12秒前
14秒前
面包恐龙完成签到,获得积分10
14秒前
14秒前
RolfHoward完成签到,获得积分10
14秒前
14秒前
小赵爱漂亮完成签到 ,获得积分10
15秒前
羊_完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189382
求助须知:如何正确求助?哪些是违规求助? 9576691
关于积分的说明 21849410
捐赠科研通 7787318
什么是DOI,文献DOI怎么找? 3435538
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509